Philips and Cognizant Collaborate in Digital Health
Royal Philips and Cognizant have announced a collaboration to develop end-to-end digital health solutions that will aim to enable healthcare organizations and life sciences companies to improve patient care and accelerate clinical trials. The alliance brings together Philips HealthSuite, a cloud-based platform and Cognizant’s digital engineering knowledge to deliver and maintain digital health solutions at scale, providing advanced connectivity and using big data to create actionable insights.
Philips HealthSuite, built on Amazon Web Services, is an integrated, modular set of standards-based capabilities that support the development of digital health propositions. The platform securely stores critical healthcare data and provides both advanced data analytics and AI capabilities. To date, more than 100 types of medical devices have been integrated into HealthSuite, with over 145 billion clinical images securely archived on the cloud platform. As part of this collaboration, Cognizant will build, deploy, implement, and operate client-specific applications on Philips HealthSuite.
With these solutions, healthcare providers can monitor their patients outside traditional clinical settings, and patients can stay more informed of their own well-being.
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
